Adult onset leukodystrophy

Gene: CST3

Amber List (moderate evidence)

CST3 (cystatin C)
EnsemblGeneIds (GRCh38): ENSG00000101439
EnsemblGeneIds (GRCh37): ENSG00000101439
OMIM: 604312, Gene2Phenotype
CST3 is in 5 panels

2 reviews

Sarah Leigh (Genomics England Curator)

I don't know

The rating of this gene has been updated to Amber and the mode of inheritance set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown following NHS Genomic Medicine Service approval.
Created: 30 Jan 2023, 5:56 p.m. | Last Modified: 30 Jan 2023, 5:56 p.m.
Panel Version: 2.46
Associated with Cerebral amyloid angiopathy, OMIM:105150, but not associated with a phenotype in Gen2Phen. A single founder variant (NM_000099.4(CST3):c.281T>A (p.Leu94Gln)) has been associated OMIM:105150 in the Icelandic population (PMIDs: 3495457; 1352269; 8108423).
Created: 5 Jan 2023, 11:04 a.m. | Last Modified: 5 Jan 2023, 11:04 a.m.
Panel Version: 2.13

Eleanor Williams (Genomics England Curator)

Review submitted on behalf of David Lynch, James Polke, Henry Houlden, Lucy Jenkins. Mode of inheritance: AD. Phenotype: Cerebral amyloid angiopathy. Evidence: MIM: 105150. Icelandic founder mutation.
Created: 22 Dec 2022, 2:01 p.m. | Last Modified: 22 Dec 2022, 2:01 p.m.
Panel Version: 2.3

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
Cerebral amyloid angiopathy

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • NHS GMS
  • Expert Review Amber
  • Expert list
Phenotypes
  • Cerebral amyloid angiopathy, OMIM:105150
  • ACys amyloidosis, MONDO:0007098
Tags
founder-effect
OMIM
604312
Clinvar variants
Variants in CST3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

30 Jan 2023, Gel status: 2

Added New Source

Sarah Leigh (Genomics England Curator)

Source NHS GMS was added to CST3.

5 Jan 2023, Gel status: 2

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: CST3 were set to 2900981; 3495457; 1352269; 3673496; 7482672

5 Jan 2023, Gel status: 2

Added Tag

Sarah Leigh (Genomics England Curator)

Tag founder-effect tag was added to gene: CST3.

5 Jan 2023, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: cst3 has been classified as Amber List (Moderate Evidence).

5 Jan 2023, Gel status: 1

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: CST3 were set to

5 Jan 2023, Gel status: 1

Set mode of inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for gene: CST3 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

5 Jan 2023, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: CST3 were changed from Cerebral amyloid angiopathy, OMIM:105150; ACys amyloidosis, MONDO:0007098 to Cerebral amyloid angiopathy, OMIM:105150; ACys amyloidosis, MONDO:0007098

5 Jan 2023, Gel status: 1

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: CST3 were changed from Cerebral amyloid angiopathy, OMIM:105150 to Cerebral amyloid angiopathy, OMIM:105150; ACys amyloidosis, MONDO:0007098

3 Jan 2023, Gel status: 1

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: CST3 were changed from to Cerebral amyloid angiopathy, OMIM:105150

22 Dec 2022, Gel status: 1

Created, Added New Source, Set mode of inheritance

Eleanor Williams (Genomics England Curator)

gene: CST3 was added gene: CST3 was added to White matter disorders - adult onset. Sources: Expert list Mode of inheritance for gene: CST3 was set to